Lunivia® (eszopiclone)

Lunivia® was granted a UK marketing authorisation on 1st June 2023.

axunio Pharma GmbH is the marketing authorisation holder for Lunivia and Leith Healthcare is axunio’s UK commercialisation partner. Further details on UK availability will follow.

Summary of Product Characteristics

Patient Information Leaflet

Products
We have a growing portfolio of healthcare products and are looking for new opportunities to partner with originator companies for UK launch

News
All the latest updates on Leith Healthcare

We use the necessary cookies to make our site work. We'd also like to set analytics cookies that help us make improvements by measuring how you use the site. These will be set only if you accept.

For more detailed information about the cookies we use, see our Cookie Policy.